Hector Ortega
Chief Medical OfficerMr. Hector Ortega, MD, Sc.D, serves as Chief Medical Officer at Prana Therapies, Inc (also known as Bolt Biotherapeutics, Inc). He is Chief Scientific Officer of Uniquity Bio, Inc. He is an accomplished allergist, immunologist and researcher who brings more than years of experience in strategic clinical development and medical affairs oversight to Uniquity Bio. Prior to joining Uniquity Bio, he was Vice President of Clinical Development at Gossamer Bio. Additionally, he has held a number of roles at GlaxoSmithKline, including Medical Expert and Senior Medical Director of Clinical Development. Under his leadership, he brought Nucala to market as a first-in-class anti-IL5 treatment for eosinophilic asthma. He has also served in leadership roles in clinical development at Roche/Genentech supporting the lebrikizumab (anti-IL-13) and Xolair (anti-IgE) programs. The recipient of numerous awards, he received the 2018 American Thoracic Society Research and Innovation and Translation Achievement Award in recognition of outstanding contributions to the advancement of respiratory research. Mr. Hector Ortega, MD, Sc.D, serves as Chief Medical Officer at Prana Therapies, Inc. He is Chief Scientific Officer of Uniquity Bio, Inc. He is an accomplished allergist, immunologist and researcher who brings more than years of experience in strategic clinical development and medical affairs oversight to Uniquity Bio. Prior to joining Uniquity Bio, he was Vice President of Clinical Development at Gossamer Bio. Additionally, he has held a number of roles at GlaxoSmithKline, including Medical Expert and Senior Medical Director of Clinical Development. Under his leadership, he brought Nucala to market as a first-in-class anti-IL5 treatment for eosinophilic asthma. He has also served in leadership roles in clinical development at Roche/Genentech supporting the lebrikizumab (anti-IL-13) and Xolair (anti-IgE) programs. The recipient of numerous awards, he received the 2018 American Thoracic Society Research and Innovation and Translation Achievement Award in recognition of outstanding contributions to the advancement of respiratory research.
Positions
- Company NameBolt Biotherapeutics, Inc.Stock CodeBOLTPositionChief Medical Officer
